Nil Albiol, MD

Hematologist
Hospital Clinic de Barcelona, Spain

Poster(s):

• 1430 - Assessing measurable residual disease (MRD) by cell-free DNA (cfDNA): results from a real-world series

• 1905 - Academic CD19-directed CAR-T ARI-0001 (varnimcabtagene autoleucel) for patients with relapsed/refractory chronic lymphocytic leukemia and Richter’s transformation